Advertisement Bovie Medical wins FDA clearance to market MEG laparoscopic line - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bovie Medical wins FDA clearance to market MEG laparoscopic line

Bovie Medical has announced that the FDA has cleared its modular ergonomic instruments, allowing the MEG line to be marketed and sold throughout the US.

The patent-pending modular forceps and accessories are said to be designed to provide surgeons added comfort while reducing per-procedure costs through the reduction of inventory and obsolescence.

According to the company, the ergonomic instruments offer a simpler assembly process for laparoscopic procedures. The modular ergonomic instruments (MEG) line is directed towards the laparoscopic market with estimated worldwide sales exceeding $425 million.

The company has also recently filed a 510(k) application with the FDA for its Icon GP generator. The Icon GP will be used as a stand-alone advanced general purpose generator as well as in conjunction with the company’s Polarian vessel sealing instruments currently under development.